AT-001 is a relaxin hormone receptor antagonist that may slow growth of androgen-independent human prostate tumor xenografts. References: Neschadim A, Pritzker LB, Pritzker KP, Branch DR, Summerlee AJ, Trachtenberg J, Silvertown JD. Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts. Endocr Relat Cancer. 2014 May 8;21(3):459-71. doi: 10.1530/ERC-14-0088. Print 2014 Jun. PubMed PMID: 24812057.

纯度：≥98%

CAS：1355612-71-3